Search
for
Sort by
Research 511–540 of 1000+
- New and Emerging Therapies for Alopecia Areata
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Mechanisms of autophagy and their implications in dermatological disorders
- Baricitinib for the Treatment of Alopecia Areata
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions against Th2 Cytokine-Mediated Signaling
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- New Modalities in the Treatment of Refractory Alopecia Areata
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Stem cell-based therapies for alopecia areata: a narrative review
- MODERN BIOLOGICAL TREATMENT METHODS FOR ALOPECIA AREATA: A COMPREHENSIVE REVIEW
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.